Quantitative Brain Function Imaging Device Market Report 2026

The quantitative brain function imaging device market size has grown strongly in recent years. It will grow from $6.09 billion in 2025 to $6.62 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to growth in neurological disorder prevalence, expansion of neuroscience research funding, rising hospital imaging infrastructure, increased use of eeg and pet systems, development of brain mapping techniques.

The quantitative brain function imaging device market size is expected to see strong growth in the next few years. It will grow to $9.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for quantitative diagnostics, growth in precision neurology, expansion of brain computer interface research, rising mental health diagnostics demand, higher investment in neurotechnology platforms. Major trends in the forecast period include multi modal brain imaging adoption, growth in functional brain mapping, integration of advanced neuro signal software, rising use in psychiatric diagnostics, expansion of portable brain monitoring systems.

The rising prevalence of neurological disorders is projected to drive the growth of the quantitative brain function imaging device market in the foreseeable future. Neurological disorders are medical conditions that affect the brain, spinal cord, or nerves, leading to impairments in movement, sensation, cognition, or other bodily functions. The increasing rate of these disorders is driven by aging populations, which raise the risk of conditions like Alzheimer’s and Parkinson’s and contribute to a mounting global healthcare burden. Quantitative brain function imaging devices assist in managing neurological disorders by providing objective, data-driven assessments of brain activity that allow for earlier diagnosis, accurate disease monitoring, and personalized treatment planning. For instance, in March 2023, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, reported that 6.7 million Americans aged 65 and older have Alzheimer’s, with projections rising to 13.8 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the expansion of the quantitative brain function imaging device market.

Leading companies operating in the quantitative brain function imaging device market are focusing on technological advancements, such as AI-based quantitative neuroimaging and imaging biomarkers, to gain more accurate diagnoses, improve clinical decision-making, and support precision neurology through objective, reproducible brain metrics. AI-based quantitative neuroimaging and imaging biomarkers refer to the use of artificial intelligence algorithms to automatically extract, measure, and analyze objective, numerical indicators from brain imaging data. For example, in December 2023, Quibim, a Spain-based healthtech company, launched QP-Brain, an AI-based quantitative brain imaging software that enables automated measurement of brain atrophy and lesion burden to support early detection and monitoring of neurological diseases. It enables early identification of subtle brain changes associated with neurodegenerative and neurological disorders. The software provides objective, reproducible imaging biomarkers that support earlier and more accurate diagnosis. By integrating directly into existing PACS workflows, it streamlines radiological reporting and reduces reliance on subjective visual assessment.

In February 2024, Philips Healthcare, a Netherlands-based provider of medical imaging solutions, partnered with Synthetic MR to integrate quantitative MRI software that allows faster, standardized measurement of brain tissue properties for neurological evaluation. Through this partnership, Philips incorporates Synthetic MR’s SyMRI NEURO 3D software with its SmartSpeed AI-enabled MRI scanners to create Smart Quant Neuro 3D, a quantitative brain imaging system offering rapid 3D measurements of brain tissue volumes, including myelin, white matter, and gray matter. SyntheticMR AB is a Sweden-based company providing a quantitative brain imaging solution that enables objective evaluation of brain tissue properties, rather than relying solely on subjective, contrast-based imaging.

Major companies operating in the quantitative brain function imaging device market are NeuroPace Inc., NeuroSky Inc, BrainsWay Ltd., Compumedics Limited, Brain Products GmbH, Emotiv Inc., Aspect Imaging Ltd., ANT Neuro/ANT North America Inc., Neuroelectrics Barcelona S.L.U., MR Solutions Ltd., Advanced Brain Monitoring Inc, Cerca Magnetics Limited, Cortech Solutions Inc., FieldLine Inc., Gowerlabs Ltd., Mitsar Co. Ltd, Mind Media B.V., Wearable Sensing LLC, Brain Vision LLC, CereHealth Corp.

Tariffs on advanced imaging hardware, precision sensors, and neurodiagnostic components are raising equipment costs in the quantitative brain function imaging device market. Import duties on scanners, electrodes, and signal acquisition modules are especially impacting high end device segments. North america and asia pacific research and hospital buyers are most affected due to dependence on imported imaging systems. Research laboratories and diagnostic centers are facing longer procurement cycles and higher capital budgets. At the same time, tariffs are encouraging regional assembly and local component sourcing strategies. Several manufacturers are expanding domestic production partnerships. This is improving regional supply resilience while keeping device prices elevated.

The quantitative brain function imaging device market research report is one of a series of new reports that provides quantitative brain function imaging device market statistics, including quantitative brain function imaging device industry global market size, regional shares, competitors with a quantitative brain function imaging device market share, detailed quantitative brain function imaging device market segments, market trends and opportunities, and any further data you may need to thrive in the quantitative brain function imaging device industry. This quantitative brain function imaging device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A quantitative brain function imaging device is a medical diagnostic system designed to measure and assess brain activity using numerical data rather than solely visual interpretation, allowing precise evaluation of brain functionality. It employs advanced methods such as functional MRI (fMRI), PET, SPECT, EEG, and near-infrared spectroscopy (fNIRS) to quantify blood circulation, oxygen usage, electrical signals, and neural connections for diagnosing, monitoring, and studying neurological and mental health conditions.

The principal components of quantitative brain function imaging devices include imaging hardware, electrodes and sensors, data acquisition systems, software platforms, accessories and consumables, and maintenance and service kits. Imaging hardware refers to the essential equipment used to capture and record brain activity, including scanners, sensors, and measurement instruments. These devices come in various types, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and near-infrared spectroscopy (NIRS), and can function in single-modal or multi-modal imaging modes. They are applied across neurological research, psychiatric research, clinical diagnostics, brain-computer interface (BCI), and cognitive neuroscience, and are utilized by hospitals, research laboratories, academic institutes, diagnostic centers, and pharmaceutical and biotechnology companies.

The quantitative brain function imaging device market includes sales of brain function imaging devices, neuroimaging scanners, functional brain mapping systems, brain activity analysis units, imaging software platforms, signal acquisition modules, data processing workstations, and visualization display systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.